All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Abstract

Polyherbal Ayurvedic Powder Effectively Reduces Blood Sugar in Streptozotocin-induced Diabetic Rats

Author(s): B. Bhattacharya and K. R. C. Reddy*
Department of Rasa Shastra, Faculty of Ayurveda, Institute of Medical Sciences, Banaras Hindu University, Varanasi-221 005, India

Correspondence Address:
Department of Rasa Shastra, Faculty of Ayurveda, Institute of Medical Sciences, Banaras Hindu University, Varanasi-221 005, India, E-mail: [email protected]


The polyherbal formulation Madhumehantak churna was studied for its efficacy at two doses using the hyperglycemia animal model of low dose streptozotocin-induced diabetic rats. The low dose Madhumehantak churna group of 1080 mg/kg/day was extrapolated from the typical 4 g thrice daily human dose used in Ayurveda. The high dose Madhumehantak churna group was 3× the low dose, equivalent to 36 g daily in humans. These groups were compared to a negative control group (non-streptozotocin-induced, non-treated), a positive control group (streptozotocin-induced, oral hypoglycemic agent-treated) and a diabetic control group (streptozotocin-induced, non-treated). Rats were fed for 28 consecutive days and monitored for plasma blood glucose. Results showed that rats with severe plasma glucose (438 and 325 mg/dl) in both low-dose Madhumehantak churna and high-dose Madhumehantak churna group re-attained almost-normal plasma glucose levels (118 and 128 mg/dl) in 28 d, reaching similar levels as the positive control, gold-standard treated group (120 mg/dl). Madhumehantak churna presents itself as a viable option for reversing hyperglycemia, as shown in this in vivo animal experimental study, and as a potentially more practical option for patients than oral hypoglycemic agents.

Full-Text | PDF